Health Care/Hospital News & Press Release Distribution

Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-11-06 08:00 2322

Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy

SHANGHAI, Nov. 4, 2023 /PRNewswire/ -- On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX101 clin...

2023-11-05 08:00 2193

Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America

Pierre Fabre Laboratories to Acquire from Atara Biotherapeutics Commercialization Rights to EBVALLO® in the United States, Canada and All Remaining Markets Pierre Fabre Laboratories to Take Over All Manufacturing, Clinical, and Regulatory Activities for EBVALLO® Following Transition Period This...

2023-11-04 00:52 1715

Verismo Therapeutics Announces Upcoming Presentation at SITC 2023

PHILADELPHIA, Nov. 3, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that it will be presenting at the upcoming Society for Immunotherapy of Cancer 38th Annual Meeting (SITC 2023), to be held in San Diego and ...

2023-11-03 21:00 1724

FEBICO Makes Strides at Vitafoods Asia, Showcasing Ambitions in Asia

TAIPEI, Nov. 3, 2023 /PRNewswire/ -- Far East Bio-Tec Co., Ltd. made significant headway at this year's Vitafoods Asia exhibition held inBangkok in September. The company, under its FEBICO brand, is taking proactive steps to expand into the global market, and its progress has not gone unnoticed. ...

2023-11-03 17:00 678

Screen health: New "Eye Comfort" Certification from TÜV Rheinland

TAIPEI, Nov. 3, 2023 /PRNewswire/ -- TÜV Rheinland has launched a new "Eye Comfort" star-rating certification for testing displays. For the certification, TÜV Rheinland experts test and classify displays in terms of eye comfort within a 5-star rating system. Especially for people who spend a lot ...

2023-11-03 14:26 940

Mediwave Unveils AI-Powered Emergency Response Suite and Smart Ambulance with Mixed Reality Tech in Malaysia

SINGAPORE, Nov. 2, 2023 /PRNewswire/ -- Mediwave, an emerging leader in healthcare technology, marked a significant milestone with the introduction of its cutting-edge end-to-end Emergency Response suite and the Smart Connected Ambulance, featuring AI and Mixed Reality technology inMalaysia. This...

2023-11-03 13:59 1067

Mediwave Unveils AI-Powered Emergency Response Suite and Smart Ambulance with Mixed Reality Tech in Malaysia

The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan

HAIKOU, China, Nov. 3, 2023 /PRNewswire/ -- On 31st Oct., the 2nd Boao International Conference on Real World Studies of Medical Products, held in Boao,Hainan, was attended by nearly 1,000 participants from domestic and international pharmaceutical regulatory agencies, academic societies, indust...

2023-11-03 12:10 546

The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan

ASH 2023 | Ascentage Pharma to Present Results from Three Clinical Studies of Bcl-2 Inhibitor Lisaftoclax (APG-2575), Including the First Data in AML and MM

SUZHOU, China, and ROCKVILLE, Md., Nov. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from three clinical studies of lisaft...

2023-11-03 09:15 517

ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting

SUZHOU, China, and ROCKVILLE, Md., Nov. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from multiple clinical studies of the ...

2023-11-03 09:10 476

FWD Group announces robust growth momentum in new business highlights

HONG KONG, Nov. 3, 2023 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced new business highlights[1] for the nine months ended 30 September 2023. New business sales grew 22 percent[2] to US$1,253 million. Value of new business increased toUS$724 million, ...

2023-11-03 08:12 18758

PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients.

* Melbourne ophthalmology company PolyActiva is developing a unique biodegradable ocular implant that provides 6 months of sustained drug delivery for patients with glaucoma, the second most common cause of irreversible blindness. * The interim Phase 2a results demonstrate a sustained >20% re...

2023-11-03 05:15 433

uLab® Announces Smart Outcomes™ for a Smart Office™--The Power and Flexibility of One Platform for Clear Aligners and Retainers

MEMPHIS, Tenn., Nov. 3, 2023 /PRNewswire/ -- uLab Systems™ announces Smart Outcomes for a Smart Office, one powerful, flexible platform designed exclusively for orthodontists, providing them with the ultimate cost-effective tool to easily create bespoke aligner treatments for each patient. The ab...

2023-11-03 00:08 451

Frost & Sullivan Honors Komodo Health with Technology Innovation Leadership Award for Its Data-Driven Platform to Improve Patient Care

Komodo Health Delivers In-Depth and Actionable Patient-Level Insights for Enterprise Customers with its Robust Real-world Data, Advanced Analytics and AI-powered Algorithms, and Clinical and Industry Expertise SAN ANTONIO and SAN FRANCISCO, Nov. 2, 2023 /PRNewswire/ -- Frost & Sullivan recently ...

2023-11-02 23:48 1014

Frost & Sullivan Honors Komodo Health with Technology Innovation Leadership Award for Its Data-Driven Platform to Improve Patient Care

Complete Genomics and Basepair™ Announce Technology Integration Partnership

SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics' DNBSEQTM sequencing platforms*. The partnership gives ...

2023-11-02 21:00 650

Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore

SINGAPORE, Nov. 2, 2023 /PRNewswire/ -- At the annual Singapore Week of Innovation and Technology (SWITCH) 2023, Lion TCR, a clinical-stage mRNA-based T cell immunotherapy company, is thrilled to announce a significant milestoneof clinching the T-Up Excellence Awards. This award, in recognitio...

2023-11-02 20:41 1551

Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore

CPIC: Harvesting Success in Insurance Services for the Greater Bay Area, Successful Hosting of the 2023 Greater Bay Area Customer Festival Press Conference

HONG KONG, Nov. 2, 2023 /PRNewswire/ -- China Pacific Insurance (Group) Co., Ltd. ("CPIC" or the "Company", Stock Code: 02601) is pleased to announce that the 2023 CPIC Greater Bay Area Customer Festival Press Conference was held in Guangzhou on the afternoon of October 31 with great success, a...

2023-11-02 20:21 1557

Boryung Successfully Concludes 'Humans In Space Symposium' at 2023 ASCEND in Las Vegas

* HIS Symposium co-located with ASCEND, the world's event designed to accelerate the building of our sustainable off-world future, fromOctober 23 to 25. * Jay Kim, the Chairman and CEO of Boryung, invited as a speaker for ASCEND's opening and closing ceremonies and the panel discussion. * B...

2023-11-02 20:00 410

Boryung Successfully Concludes 'Humans In Space Symposium' at 2023 ASCEND in Las Vegas

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)

* FDA granted Breakthrough Therapy Designation for felzartamab in PMN upon positive clinical data from M-PLACE, a Phase 2 study led by I-Mab partner HI-Bio * I-Mab has full development and commercialization rights of felzartamab in Greater China for all indications, with Phase 3 multiple myelom...

2023-11-02 20:00 857

Ivonescimab's Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023

Potential First-in-Class Tetravalent Bispecific Antibody Demonstrates Enhanced Binding inthe Simultaneous Presence of PD-1 & VEGF Cooperative Binding of Ivonescimab Enables Higher Avidity in the Tumor Microenvironmentwith Over 18 Fold Increased Binding Affinity to PD-1 in the Presence of VEGF in...

2023-11-02 20:00 458